2022Veterinary Medicine and ScienceOpen access

Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats

Atefeh Nahvi, Mohammad Mahdi Molaei, Amir Saeed Samimi, Omid Azari, Hossein Mashayekhi, Fatemeh Ebrahimzadeh

Open full text 9 citations

Abstract

Abstract Background Many α2‐agonists are commonly used for sedation and analgesia in ruminants. Introduction The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. Methods Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg−1); detomidine (50 μg kg−1); medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. Results Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α2‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α2‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α2‐adrenergic agonists’ administration. Ruminal motility was decreased in α2‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α2‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. Conclusions The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg−1), detomidine (50 μg kg−1), medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats.

Open-access reader

About this research paper

What this paper is about

Abstract Background Many α2‐agonists are commonly used for sedation and analgesia in ruminants. Introduction The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. Methods Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg−1); detomidine (50 μg kg−1); medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. Results Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α2‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α2‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α2‐adrenergic agonists’ administration. Ruminal motility was decreased in α2‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α2‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. Conclusions The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg−1), detomidine (50 μg kg−1), medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Background Many α2‐agonists are commonly used for sedation and analgesia in ruminants. Introduction The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. Methods Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg−1); detomidine (50 μg kg−1); medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. Results Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α2‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α2‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α2‐adrenergic agonists’ administration. Ruminal motility was decreased in α2‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α2‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. Conclusions The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg−1), detomidine (50 μg kg−1), medetomidine (20 μg kg−1) and dexmedetomidine (5 μg kg−1) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats.

Key concepts: Detomidine, Medetomidine, Xylazine, Dexmedetomidine, Sedation, Sedative, Atipamezole, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats — Research Paper | ScholarLens